M
M. Cianfrocca
Researcher at Fox Chase Cancer Center
Publications - 5
Citations - 700
M. Cianfrocca is an academic researcher from Fox Chase Cancer Center. The author has contributed to research in topics: Breast cancer & Cancer. The author has an hindex of 4, co-authored 5 publications receiving 676 citations.
Papers
More filters
Journal ArticleDOI
Prognostic and predictive factors in early-stage breast cancer.
M. Cianfrocca,Lori J. Goldstein +1 more
TL;DR: The purpose of adjuvant systemic therapy is to eradicate distant micrometastatic deposits, and it is essential to be able to estimate an individual patient's risk of harboring clinically silent micromETastatic disease using established prognostic factors.
Journal ArticleDOI
A phase I and pharmacokinetic study of lapatinib in combination with letrozole in patients with advanced cancer.
Quincy Chu,M. Cianfrocca,Lori J. Goldstein,Meg Gale,Nicholas P. Murray,Jill Loftiss,Nikita Arya,Kevin M. Koch,Lini Pandite,Ronald A. Fleming,Elaine M. Paul,Eric K. Rowinsky +11 more
TL;DR: Clinically relevant doses of lapatinib in combination with letrozole were well tolerated and did not result in a pharmacokinetic interaction, and clinical antitumor activity was observed.
Journal ArticleDOI
A phase I, open-label study of the safety, tolerability and pharmacokinetics of lapatinib (GW572016) in combination with letrozole in cancer patients
Quincy Chu,Lori J. Goldstein,Nicholas P. Murray,Eric K. Rowinsky,M. Cianfrocca,M. Gale,Peter T.C. Ho,Elaine M. Paul,Jill Loftiss,Lini Pandite +9 more
TL;DR: Patients with advanced breast cancer, ER or PR +, or other tumors that would be likely to respond to the combination therapy were enrolled and the optimally tolerated regimen (OTR) was determined.
Journal ArticleDOI
Operable breast cancer
M. Cianfrocca,Lori J. Goldstein +1 more
TL;DR: It is standard clinical practice to administer adjuvant systemic therapy to patients with node-positive and high-risk, node-negative breast cancer.
Journal ArticleDOI
Screening mammography is associated with earlier stage disease and greater eligibility for breast conservation in women aged 4o and older with breast cancer
Gary M. Freedman,Penny R. Anderson,Lori J. Goldstein,A.L. Hanlon,Michael Millenson,M. Cianfrocca,M. von Mehren,Marcia Boraas,Michael H. Torosian,Elin R. Sigurdson,John P. Hoffman,Nicos Nicolaou,A Magilner,Kathryn Evers +13 more